What is the definition and management of a stage 3 (full-thickness skin loss) ulcer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition and Management of Stage 3 Ulcers

A stage 3 ulcer is defined as a full-thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia, presenting as a deep crater with or without undermining of adjacent tissue. 1

Characteristics of Stage 3 Ulcers

  • Stage 3 ulcers involve full-thickness skin loss with damage to subcutaneous tissue but not extending to muscle, tendon, or bone 1
  • These ulcers typically present as deep craters that may contain slough (yellow, tan, gray, green, or brown tissue) in the wound bed 1
  • Slough is commonly found in Stage 3 pressure injuries and presents as a layer of dead tissue in the wound bed 1
  • Stage 3 ulcers may have undermining or tunneling into surrounding tissues 2
  • In diabetic foot ulcers, a Stage 3 equivalent (Wound Grade 3 in the WIfI system) is described as an "extensive, deep ulcer involving forefoot and/or midfoot; deep, full thickness heel ulcer with calcaneal involvement" 3

Assessment of Stage 3 Ulcers

  • Documentation should include size, location, presence of slough and granulation tissue, exudate amount and characteristics, odor, presence of sinus tracts, undermining, and signs of infection 2
  • Evaluate vascular status, especially in lower extremity ulcers, considering ankle pressure or ABI measurements 4
  • Assess for signs of infection such as increasing pain, erythema, warmth, or purulent drainage 4
  • Inspect the ulcer thoroughly to determine the extent of tissue damage and necrosis 4

Management Approach

Debridement

  • Sharp debridement is the preferred method for removing slough and necrotic tissue from Stage 3 ulcers 1, 4
  • Urgent sharp debridement should be performed if advancing cellulitis or sepsis occurs 2
  • Alternative debridement methods include:
    • Autolytic (using hydrogels) for cases where sharp debridement is contraindicated 1
    • Biological (larval therapy) 1
    • Enzymatic (collagenase) 1
  • Repeat debridement as needed until all necrotic tissue is removed 4

Wound Cleansing and Dressing

  • Cleanse wounds preferably with normal saline 2
  • Select appropriate dressings based on wound characteristics:
    • Alginates or foams for moderately exudative wounds 4
    • Continuously moistened saline gauze or hydrogels for dry wounds 4
    • Avoid silver or antimicrobial agent-containing dressings unless specifically indicated 4
  • Dressings should be selected based on exudate control, comfort, and cost after slough removal 1

Infection Management

  • Bacterial load can be managed with proper cleansing 2
  • Consider topical antibiotics if there is no improvement in healing after 14 days 2
  • Use systemic antibiotics for advancing cellulitis, osteomyelitis, or systemic infection 2
  • If infection is present, empiric antibiotic therapy should target S. aureus and streptococci for superficial infections 4

Pressure Offloading

  • Ensure complete offloading of pressure from the affected area 4
  • Follow a patient repositioning schedule 2
  • Keep the head of the bed at the lowest safe elevation to prevent shear 2
  • Use pressure-reducing surfaces 2
  • For heel ulcers, consider shoe modifications, temporary footwear, or orthoses 4

Nutrition

  • Assess nutrition status and provide supplementation if needed 2
  • Optimize glycemic control in diabetic patients 3

Advanced Therapies for Non-Healing Stage 3 Ulcers

  • Consider vascular assessment and possible revascularization if healing is delayed 4
  • Evaluate for systemic hyperbaric oxygen treatment for poorly healing wounds 4
  • For recalcitrant ulcers, dermal substitutes including skin from cadaver donors may increase healing rates 5
  • Complex wound reconstruction may be required for extensive Stage 3 ulcers, particularly in the sacrococcygeal region 6

Clinical Pitfalls to Avoid

  • Mistaking slough for biofilm can lead to inappropriate treatment strategies 1
  • Failing to remove slough can result in increased risk of infection and delayed wound healing 1
  • Aggressive debridement in patients with severe ischemia requires careful consideration of risks versus benefits 1
  • Neglecting to assess for and treat underlying causes (e.g., pressure, poor circulation) will result in poor healing outcomes 2
  • Underestimating the importance of nutrition in wound healing 2

References

Guideline

Wound Slough Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pressure ulcers: prevention, evaluation, and management.

American family physician, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Stage 2 Left Heel Pressure Injury with Necrotic Tissue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cadaveric Skin Grafts May Greatly Increase the Healing Rate of Recalcitrant Ulcers When Used Both Alone and in Combination With Split-Thickness Skin Grafts.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020

Research

Wound Management of Multi-Site Pressure Ulcer at Different Stages in Elderly Patients.

Clinical, cosmetic and investigational dermatology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.